Tumor suppressor miR-449a inhibits the development of gastric cancer via down-regulation of SGPL. Issue 46 (19th July 2018)

• Record Type: Journal Article
• Authors: Chen, Qian; Yang, Zhen; Pan, Gaofeng; Ding, Hongjian; Jiang, Daowen; Huang, Jianfang; Liu, Weiyan
• Is Part Of: RSC advances. Volume 8:Issue 46(2018)
• Page Start: 26020
• Page End: 26028
• Publication Date: 2018-07-19
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c8ra02722f
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : MicroRNAs (miRNAs) are small noncoding RNAs that are known to participate in the regulation of many physiological and pathological processes, which can indirectly influence the development of malignant behaviors. Abstract : MicroRNAs (miRNAs) are small noncoding RNAs that are known to participate in the regulation of many physiological and pathological processes, which can indirectly influence the development of malignant behaviors. Numerous studies have demonstrated that miR-449a plays important roles in human carcinogenesis. However, its precise functional and regulatory roles remain unclear. In this study, we mainly explored the functional role of miR-449a in gastric cancer (GC). The expression levels of miR-449a in 98 cases of GC tissues and cell lines were determined by qRT-PCR. The possible mechanisms of miR-449a in GC cells were explored by fluorescence reporter assay. miR-449a expression was significantly lower in GC tissues compared to matched para-carcinoma tissues and was associated with tumor differentiation. Furthermore, in vitro knockdown of miR-449a by siRNA significantly inhibited MKN-28 cell proliferation, migration and invasion as well as tumorigenesis via inducing G0/G1 arrest of GC cells. In addition, we identified SGPL1 as a target of miR-449a and demonstrated that miR-449a regulated SGPL1 expression via binding its 3′-UTR region. The experiments indicated that miR-449a functions as a novel tumor suppressor in GC and its anti-oncogenic activity may involve its inhibition of the target gene SGPL1. These findings suggested that miR-449a may be a promising candidate for the development of antitumor drugs targeting GC.